New antibiotic prevents bacteria from returning
A research group at the Leiden Institute of Biology (IBL) has developed a new antibiotic against the pathogenic intestinal bacterium Clostridioides difficile.
1 to 6 of 129 results
Pharmaceutical company Eli Lilly is constructing a new factory in Katwijk.
Eli Lilly, one of the largest pharmaceutical companies in the world, is setting up a new factory in Katwijk, close to Leiden Bio Science Park. It is estimated that the factory will create 500 jobs for the region.
The new future with AI
AI is developing rapidly and is influencing virtually all aspects of our society, such as research and education. However, these developments also entail risks.
Europe better prepared for pandemics
The biotech company Leyden Labs from Leiden has received an investment of €30 million for their new medicine, the PanFlu nasal spray. The nasal spray offers protection against flu viruses by leaving antibodies in the nose.
Robotic surgery makes history in Leiden
The LUMC was the first in the Netherlands to perform a liver transplant using a living donor and a surgical robot. This breakthrough is a major step forward in robotic surgery and increases the chances for patients to receive a donor liver.
Rapidemic receives $2.7 million grant to improve rapid STI diagnostics
Rapidemic, based in Leiden Bio Science Park, has received £2.7 million in funding from the Bill & Melinda Gates Foundation for its rapid test for detecting the STDs Chlamydia trachomatis and Neisseria gonorrhoeae.